Industry Leaders’ Fireside Chat: A Commercial TCR-T & TCR Bispecific – What’s Next?
Time: 2:15 pm
day: Day 1
Details:
• Reflecting on the past: celebrating the first TCR-T commercial approval and its impact on the field, along with novel clinical data
• Determining the current state of play: discussing what challenges remain, the current funding environment and the priority for the field to outline present focus
• What’s next? Discussing the potential for allogeneic or in vivo approaches, scalable manufacturing and expansion to novel patient populations
